Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer.
Friedman CF, Snyder Charen A, Zhou Q, Carducci MA, Buckley De Meritens A, Corr BR, Fu S, Hollmann TJ, Iasonos A, Konner JA, Konstantinopoulos PA, Modesitt SC, Sharon E, Aghajanian C, Zamarin D.
Friedman CF, et al. Among authors: sharon e.
J Immunother Cancer. 2020 Oct;8(2):e001126. doi: 10.1136/jitc-2020-001126.
J Immunother Cancer. 2020.
PMID: 33004542
Free PMC article.
Clinical Trial.